Marta Daniela Costa (Marta D Costa)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Combination Therapy

Cell Cycle Arrest

Endoplasmic Reticulum Stress

Top Venues

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Luísa Carvalho, Fábio Pedroso de Lima, Mónica Cerqueira, Ana Silva, Olívia Pontes, Sofia Oliveira-Pinto, Sara R Guerreiro, Marta Daniela Costa, Sara Granja, Patrícia Maciel, Adhemar Longatto-Filho, Fátima Baltazar, Fernanda Proença, Marta Freitas Costa
In vitro and in vivo evaluation of novel chromeno[2,3- d ]pyrimidinones as therapeutic agents for triple negative breast cancer. RSC medicinal chemistry 15 (4) (2024)
Luísa Carvalho, Fábio Pedroso de Lima, Mónica Cerqueira, Ana Silva, Olívia Pontes, Sofia Oliveira-Pinto, Sara R Guerreiro, Marta Daniela Costa, Sara Granja, Patrícia Maciel, Adhemar Longatto-Filho, Fátima Baltazar, Fernanda Proença, Marta Freitas Costa
In vitro and in vivo evaluation of novel chromeno[2,3- d ]pyrimidinones as therapeutic agents for triple negative breast cancer. RSC medicinal chemistry 15 (4) (2024)
Filipa Almeida, Ildete L Ferreira, Luana Naia, Daniela Marinho, Ana Catarina Vilaça-Ferreira, Marta Daniela Costa, Sara Duarte-Silva, Patrícia Maciel, Ana Cristina Rego
Mitochondrial Dysfunction and Decreased Cytochrome c in Cell and Animal Models of Machado-Joseph Disease. Cells 12 (19) (2023)
Ana Jalles, Cármen Vieira, Patrícia Maciel, Daniela Vilasboas-Campos, Ana Francisca Mota, Sara Vasconcelos, Bruna Ferreira-Lomba, Marta Daniela Costa, Jorge Diogo Da Silva, Patrícia Maciel, Andreia Teixeira-Castro
Aripiprazole Offsets Mutant ATXN3-Induced Motor Dysfunction by Targeting Dopamine D 2 and Serotonin 1A and 2A Receptors in C. elegans . Biomedicines 10 (2) (2022)